Research benefits for hypothetical HIV vaccine trials: The views of Ugandans in the Rakai District.

Opinion Leaders (OL) 150 opinion leaders identified through SOLnet and 50 randomly chosen community mobilizers. Males and females. Not receiving study compensation. Community opinion leaders in three Rakai District community clusters who were identified through a separate sociometric survey (SOLnet study) and/or selected based on their local council leadership status. a. Formerly Community HIV Epidemiology Research (CHER). Molecular Epidemiology Research (MER) 125 males randomly selected from >600 seroconverters. Research participants in a substudy to characterize HIVsubtypes and viral set points among recent HIV seroconverters identified through the RCCS.